Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?

by Angelina Cistaro, Natale Quartuccio, Alireza Mojtahedi, Piercarlo Fania, Pier Luigi Filosso, Mariapaola Cucinotta, Alfredo Campennì, Umberto Ficola, Sergio Baldari
Published 2013-01-01

Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy

by Marco Chiappetta, Filippo Lococo, Giovanni Leuzzi, Isabella Sperduti, Emilio Bria, Leonardo Petracca Ciavarella, Felice Mucilli, Pier Luigi Filosso, Giovannibattista Ratto, Lorenzo Spaggiari, Francesco Facciolo, Stefano Margaritora
Published 2021-03-01

The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.

by Francesco Guerrera, Fabrizio Tabbò, Luca Bessone, Francesca Maletta, Marcello Gaudiano, Elisabetta Ercole, Laura Annaratone, Maria Todaro, Monica Boita, Pier Luigi Filosso, Paolo Solidoro, Luisa Delsedime, Alberto Oliaro, Anna Sapino, Enrico Ruffini, Giorgio Inghirami
Published 2016-01-01